Gilead Signs Sales Deal with Glaxo for Viread | Pharmaceutical Processing
Links shared publicly online about this topic.
- 1,579total visits
Gilead Signs Sales Deal with Glaxo for Viread | Pharmaceutical Processing
NEW YORK (AP) --" Gilead Sciences Inc. and GlaxoSmithKline said Tuesday they signed a deal to sell Viread as a hepatitis B treatment in Asia. Gilead makes Viread, which is also used to treat HIV.
View full resource at pharmpro.com
Tags: Hepatitis B Medication, HIV Medication, Pharma, Viread, GlaxoSmithKline, Gilead Sciences, Science
Most Recently Shared on November 24, 2009 at 3:15 pm By:
RT @PharmProEditor: Gilead Signs Sales Deal with Glaxo for Viread. http://bit.ly/8p5CQv
Advertisement
